ATS Business Model and Strategic M&A Impact
Capital Allocation Focused on Expanding Positions in
Regulated Markets & Compounding Growth Through M&A
13
Targeting Value Creation in Attractive Markets
What We Look For
Growth orientated
Attractive
Markets
■Low cyclicality
Strategic
Value
■Regulated spaces
■■Differentiated technology
Innovative products
■Niche applications
■Geographic penetration
Operational
Fit
Ability to manage
■Synergy potential
Recent Acquisitions
→SP
Acquired: Dec 2021
Price: US$450mm
CFT
LEADERS
INNOVATE.
Acquired: Mar 2021
Price: ~C$260mm
5
End Market Exposure
Life Sciences
Food
Financial
Returns
ABM implementation
ROIC > Cost of capital
■Strong EBITDA potential
Recurring revenue
EPS accretion
COMECER
Acquired: Feb 2019
Price: €113mm
Other Acquisitions
Triad
Reliability Engineering Provider
Acquired: Mar 2023
BioDot
Fluid Dispensing Equipment
Provider
Acquired: Jun 2021
Zi-Argus
Automation system integrator
Acquired: Mar 2023
DF S.r.l
Pharma Equipment Provider
Acquired: Nov 2021
IPCOS
Production Process Optimization
Acquired: Dec 2022
BLSG
Process Engineering Consultant
Acquired: Aug 2021
$1.4 billion of M&A capital successfully deployed since 2017
Life Sciences
HSG
Pharma system integrator
Acquired: Dec 2021
NCC
Precision Conveyance Provider
Acquired: Sep 2021View entire presentation